Authors: LOPESVIRELLA M KOSKINEN S VIRELLA G ORCHARD TJ

Citation: M. Lopesvirella et al., OXIDIZED LDL ANTIBODIES AND IMMUNE-COMPLEXES PREDICT CORONARY-ARTERY DISEASE (CAD) IN TYPE-1 DIABETES, Diabetes, 47, 1998, pp. 205-205

Authors: MIRONOVA M VIRELLA G LOPESVIRELLA M

Citation: M. Mironova et al., ISOLATION AND CHARACTERIZATION OF HUMAN AUTOANTIBODIES AGAINST OXIDIZED LDL, The FASEB journal, 9(4), 1995, pp. 1030-1030

Authors: VIRELLA G MIRONOVA M VIRELLA I LOPESVIRELLA M

Citation: G. Virella et al., COMPETITIVE VS DIFFERENTIAL ASSAYS FOR ANTIBODIES TO MODIFIED LDL, The FASEB journal, 9(4), 1995, pp. 1030-1030

Authors: JENKINS A CHASSEREAU C KLEIN R LOPESVIRELLA M

Citation: A. Jenkins et al., IN-VITRO LDL OXIDIZABILITY IS NOT INCREASED IN PATIENTS WITH WELL-CONTROLLED IDDM, Diabetes, 44, 1995, pp. 43-43

Authors: JOKL R KLEIN RL JENKINS AJ LOPESVIRELLA M COLWELL JA

Citation: R. Jokl et al., ORAL VITAMIN-E SUPPLEMENTATION DOES NOT AFFECT PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI) RELEASE IN NIDDM PATIENTS, Diabetes, 44, 1995, pp. 62-62